Go Symbol Lookup
Loading...

Hammerson Sells 50% Stake in British Shopping Mall

 Text Size  
Published: Tuesday, 17 Jul 2007 | 10:27 AM ET
By: AP

Hammerson, a British real-estate company that also operates in France, said Tuesday it sold a 50% interest in WestQuay Shopping Centre, Southampton, to an affiliate of GIC Real Estate for 299 million pounds ($608.1 million; 441.8 million euros) in cash.

Hammerson and GIC Real Estate, the real estate investment arm of the Government of Singapore Investment, will each hold their respective 50% stakes in WestQuay in a joint venture partnership, with Hammerson acting as asset manager.

WestQuay had an asset value of 588 million pounds ($1.2 billion; 868.8 million euros) as of Dec. 31 and generates net rental income of about 25 million pounds a year ($50.9 million; 36.9 million euros). Hammerson will use the proceeds to finance its development program.

 Print
Hammerson, a British real-estate company that also operates in France, said Tuesday it sold a 50%  interest in WestQuay Shopping Centre, Southampton, to an affiliate of GIC Real Estate for 299 million pounds ($608.1 million; 441.8 million euros) in cash.

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Discussing the state of Detroit's economy, with CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum.

  • Larry Kudlow discusses the journalistic merit of a Financial Times article, which triggered a brief sell-off in U.S markets. Larry McDonald, Newedge; Ed Butowsky, Chapwood Investments; and Ron Kruszewski, Stifel Nicolaus join in the discussion later.

  • The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum, discuss.